大鼠脑组织含磷代谢物随年龄变化的NMR研究
收稿日期: 2016-02-03
修回日期: 2016-04-09
网络出版日期: 2016-06-05
基金资助
国家自然科学基金青年基金资助项目(30801207).
NMR-Based Analysis of Age-Related Changes of Phosphate Metabolites in Rat Brain
Received date: 2016-02-03
Revised date: 2016-04-09
Online published: 2016-06-05
随着人口老龄化的不断加剧,衰老相关疾病已成为全球关注的问题.神经系统功能的退行性改变居于衰老相关疾病的首位,其机制尚不明了.该文旨在通过核磁共振磷谱(31P NMR)检测不同月龄大鼠脑组织中小分子物质的改变,明确能量相关的含磷化合物随大鼠年龄增长的变化,从而揭示脑组织中年龄相关代谢物的变化规律.该研究萃取了不同年龄(幼年、中年及老年)Sprague-Dawley(SD)大鼠脑组织中的小分子物质,进行了31P NMR检测分析.结果显示:老年大鼠脑组织中能量代谢相关物质——磷酸肌酸的含量显著升高,而磷脂酰胆碱及磷酸肌醇含量显著降低,并且出现了磷酸化葡萄糖.这一发现有助于理解衰老相关的脑结构和功能下调,为神经退行性疾病的发生提供依据.
关键词： 核磁共振磷谱(31P NMR); 代谢; 衰老; 脑组织
孙鹏 , 刘买利 , 张许 , 马婧 , 张先荣 . 大鼠脑组织含磷代谢物随年龄变化的NMR研究[J]. 波谱学杂志, 2016 , 33(2) : 236 -243 . DOI: 10.11938/cjmr20160206
With advances in population aging, age-related diseases have become a global problem. Neurodegenerative disease is one type of leading aging associated diseases, the mechanism of which remains elusive. In the present study, 31P NMR spectroscopy was used to characterize alterations of small molecules in rat brain for different age group, and identify alterations of energy associated phosphorylated compounds with aging, which will be helpful for interpreting age-related metabolism in brain. Results showed that energy related metabolite phosphocreatine increased significantly, whereas phosphatidylcholine and phosphorylcholine reduced significantly in aged rat brain. Interestingly, glucose phosphates appeared in aged rat brain. This study demonstrated the alterations of phospholipid metabolism in rat brain with aging, which may help to understand the development of neurodegeneration, and these metabolites may be used as molecular markers for monitoring neurodegenerative disorders.
Key words： 31P NMR; metabolism; aging; brain
[1] Chen Z, Yu J, Song Y T, et al. Aging Beijing:Challenges and strategies of health care for the elderly[J]. Ageing Res Rev, 2010, 9(Suppl 1):S2-S5.
[2] Wilson R S, Bienias J L, Berry-Kravis E, et al. The apolipoprotein E epsilon 2 allele and decline in episodic memory[J]. J Neurol Neurosurg Psychiatry, 2002, 73(6):672-677.
[3] Morrison J H, Hof P R. Life and death of neurons in the aging brain[J]. Science, 1997, 278(5337):412-419.
[4] Sowell E R, Peterson B S, Thompson P M, et al. Mapping cortical change across the human life span[J]. Nat Neurosci, 2003, 6(3):309-315.
[5] Nicholson J K, Connelly J, Lindon J C, et al. Metabonomics:a platform for studying drug toxicity and gene function[J]. Nat Rev Drug Discov, 2002, 1(2):153-161.
[6] Sibille E. Molecular aging of the brain, neuroplasticity, and vulnerability to depression and other brain-related disorders[J]. Dialogues Clin Neurosci, 2013, 15(1):53-65.
[7] Zhang X R, Wu J F, Liu H L, et al. Age- and gender-related metabonomic alterations in striatum and cerebellar cortex in rats[J]. Brain Res, 2013, 1507:28-34.
[8] Zhang X R, Liu H L, Wu J F, et al. Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats[J]. Neurochem Int, 2009, 54(8):481-487.
[9] Norris S E, Friedrich M G, Mitchell T W, et al. Human prefrontal cortex phospholipids containing docosahexaenoic acid increase during normal adult aging, whereas those containing arachidonic acid decrease[J]. Neurobiol Aging, 2015, 36(4):1659-1669.
[10] Reddy R, Keshavan M S. Phosphorus magnetic resonance spectroscopy:Its utility in examining the membrane hypothesis of schizophrenia[J]. Prostaglandins Leukot Essent Fatty Acids, 2003, 69(6):401-405.
[11] Forester B P, Berlow Y A, Harper D G, et al. Age-related changes in brain energetics and phospholipid metabolism[J]. NMR Biomed, 2010, 23(3):242-250.
[12] Lutz N W, Cozzone P J. Multiparametric optimization of 31P NMR spectroscopic analysis of phospholipids in crude tissue extracts. 1. Chemical shift and signal separation[J]. Anal Chem, 2010, 82:5433-5400.
[13] Fan T W M, Lane A N. Structure-based profiling of metabolites and isotopomers by NMR[J]. Prog Nucl Magn Reson Spectrosc, 2016, (92, 93):54-70.
[14] Niere J O, Griffith J M, Grant B R. 31P NMR studies on the effect of phophite on Phytophthora palmivora[J]. J Gen Microbiol, 1990, 136(1):147-156.
[15] Schlattner U, Tokarska-Schlattner M, Wallimann T, et al. Mitochondrial creatine kinase in human health and disease[J]. Biochim Biophys Acta, 2006, 1762(2):164-180.
[16] Rambo L M, Ribeiro L R, Della-Pace I D, et al. Acute creatine administration improves mitochondrial membrane potential and protects against pentylenetetrazol-induced seizures[J]. Amino Acids, 2013, 44(3):857-868.
[17] Cunha M P, Martin-de-Saavedra M D, Romero A, et al. Both creatine and its product phosphocreatine reduce oxidative stress and afford neuroprotection in an in vitro Parkinson's model[J]. ASN Neuro, 2014, 6(6). 1759091414554945.
[18] Oliveira J M. Mitochondrial bioenergentics and dynamics in Huntington's disease:Tripartite synapses and selective striatal degeneration[J]. J Bioenerg Biomembr, 2010, 42(3):227-234.
[19] Tsui M M, York J D. Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes[J]. Adv Enzyme Regul, 2010, 50(1):324-337.
[20] Windhorst S, Minge D, Bähring R, et al. Inositol-1,4,5-trisphosphate 3-kinase:A regulates dendritic morphology and shapes synaptic Ca2+ transients[J]. Cell Signal, 2012, 24(3):750-757.
[21] López-Téllez J F, López-Aranda M F, Navarro-Lobato I, et al. Prefrontal inositol triphosphate is molecular correslate of working memory in nonhuman primates[J]. J Neurosci, 2010, 30(8):3067-3071.
/
| 〈 |
|
〉 |